We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Calliditas Therapeutics AB | NASDAQ:CALT | NASDAQ | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
1.52 | 3.95% | 39.99 | 38.68 | 39.97 | 40.00 | 38.8001 | 39.16 | 49,364 | 22:02:20 |
STOCKHOLM, May 16, 2024 /PRNewswire/ -- Calliditas's interim report for the first quarter, January - March 2024 will be published in Swedish and English on Thursday 23 May 2024 at 07.00 a.m. CET.
A combined audio cast and telephone conference with the opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, CMO Richard Philipson and President North America Maria Törnsén.
The presentation will be given in English.
Link to the webcast:
Calliditas Therapeutics Q1 Report 2024 (financialhearings.com)
To participate via conference call please register via this link: https://conference.financialhearings.com/teleconference/?id=50047214
After registration, you will receive a phone number and a conference ID to log in to the conference call. Via the telephone conference, there is an opportunity to ask oral questions.
For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel. +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency of the contact person set out above, on 16 May, 2024, at 8:30 a.m. CET.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/calliditas-therapeutics/r/invitation-to-the-presentation-of-calliditas-s-interim-report-january---march-2024,c3982567
The following files are available for download:
https://mb.cision.com/Main/16574/3982567/2801057.pdf | Invitation to the presentation of Calliditas_Q1 2024 |
View original content:https://www.prnewswire.com/news-releases/invitation-to-the-presentation-of-calliditass-interim-report-january--march-2024-302147351.html
SOURCE Calliditas Therapeutics
Copyright 2024 PR Newswire
1 Year Calliditas Therapeutics AB Chart |
1 Month Calliditas Therapeutics AB Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions